Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesLong-term follow-up of prenatally treated children at risk for congenital adrenal hyperplasia: does dexamethasone cause behavioural problems
European Journal of Endocrinology, 08/28/08
Hirvikoski T et al. - DEX-treated children showed good overall adjustment. The parent–child agreement with respect to social anxiety was modest, highlighting the importance of multiple information sources and assessment methods. The clinical significance of the observed difference in sociability cannot be determined within the frameworks of this study.
| Previous Article | Next Article |
Today in Adrenal Glands...keeping you current
Receive free subspecialty "5-minute updates" via email
Management of adrenal incidentaloma
Best Practice & Research Clinical Endocrinology & Metabolism, 06/18/09
Therapeutic management of adrenal insufficiency
Best Practice & Research Clinical Endocrinology & Metabolism, 06/12/09
Management of the child with congenital adrenal hyperplasia
Best Practice & Research Clinical Endocrinology & Metabolism, 06/10/09
Today in Pediatric Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Metformin for obesity in children and adolescents: a systematic review
Diabetes Care, 06/11/09
Effects of topiramate on weight and metabolism in children with epilepsy
Acta Pediatrica, 06/09/09
Insulin pumps for children
Paediatrics and Child Health, 06/16/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Denosumab update
Current Opinion in Rheumatology, 06/11/09
Lipid-altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients with hypercholesterolemia and the metabolic syndrome (from the VYMET study)
The American Journal of Cardiology, 06/22/09
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): A multicentre, randomised, open-label trial
The Lancet - Early Online Publication, 06/09/09
Sponsor
Article Search
Sponsor